Background Smoking prevalence and the associated poor health and mortality is
significantly higher among people with/recovering from problematic drug or alcohol (PDA) …

Introduction Smoking prevalence among those in substance misuse treatment remains
much higher than the general population, despite evidence for effective cessation …

Introduction Smoking-related diseases are major contributors to disability and shorter life
expectancy among opioid-dependent patients. Smoking prevalence is considerably higher …

Introduction Veterans with mental health disorders smoke at high rates, but encounter low
rates of tobacco treatment. We sought to understand barriers and facilitators to treating …

Tobacco use is disproportionately elevated among patients with substance use disorders
relative to the general US population. Tobacco interventions are lacking within substance …

People with substance-use disorders have elevated rates of tobacco use compared with the
general population, yet rarely receive tobacco-dependence treatment within substance-use …

Abstract Introduction The QuitNic pilot trial aimed to test the feasibility of providing a nicotine
vaping product (NVP) compared with combination nicotine replacement therapy (NRT) to …

Third-party observers' opinions affect how organizations handle sexual harassment. Prior
research has focused on perceptions of sexual harassment targeting straight cisgender …

Among Americans with substance use disorders (SUDs), polysubstance use is the rule
rather than the exception. SUDs are identified by a pattern of problematic behaviors …

Introduction Tobacco smoking is highly prevalent among alcohol and other drugs (AOD)
service clients and, despite interest in quitting, abstinence is rarely sustained. Nicotine …